跳至主要内容
临床试验/NCT06507215
NCT06507215已完成不适用

Cross-sectional Study to Evaluate the Frequency of Dysferlinopathy Carriers in the Caucasian Population Using a Test for Detecting the Dysferlin Protein in Peripheral Blood Monocytes.

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2012年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
149
试验地点
1
主要终点
Dysferlin Expression Levels by age and gender

研究概览

简要总结

The objective of the study is to answer the following important questions. Deficiency of the dysferlin protein is the cause of a very rare limb-girdle muscular dystrophy (LGMD-2B) that leads to significant disability. This disease is caused by mutations in the dysferlin gene. It is a recessive inherited disease, meaning that both copies of the gene must have mutations for the disease to develop. This study aims to analyze the frequency of carriers of a mutation in the DYSF gene in the Caucasian population. To achieve this, The investigator analyzed the blood of 100 healthy volunteers from their local area, quantifying the dysferlin protein in peripheral blood monocytes.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals diagnosed with dysferlinopathies.
  • Carriers of a single mutation in the DYSF gene.
  • Participants who are willing to undergo treatment with oral vitamin D
  • Subjects who can provide informed consent for participation in the study.
  • Controls and carriers willing to participate in in vitro studies using HL60 cells, monocytes, and myotubes.

排除标准

  • Individuals with conditions or medications that could interfere with the study outcomes of dysferlin expression.
  • Participants who are unwilling or unable to adhere to the study protocol for the duration of the study period.
  • Pregnant or breastfeeding women.
  • Individuals with known allergies or adverse reactions to vitamin D3 supplements.
  • Subjects with severe concurrent illnesses that may impact the study's objectives or their ability to participate effectively.

结局指标

主要结局

Dysferlin Expression Levels by age and gender

时间窗: 1 month

Dysferlin expresion lels in monocytes by western blotting

次要结局

  • Identification of Carries by Protein Level(1 month)
  • Percentage of Predicted Carriers Showing Specific Genetic Mutations(1 month)
  • Percentage of DNA Methylation in Target Gene(1 month)

研究者

发起方
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验